Oncology CME

Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Up Close and Personalizing Gastric Cancer Care: Precision Medicine With HER2-Targeted Therapies and Other Novel Agents
David H. Ilson, MD, PhD
July 8, 2020
Credits: 1.00 CME / MOC / CPE
Medical Learning Institute, Inc.
Teaming Up to Reduce the Burden of Cancer-Associated VTE: Applying the Latest Guidelines and Evidence in Gastrointestinal and Hematologic Malignancies and Other Cancer Settings
Alok A. Khorana, MD, FACP, FASCO
July 2, 2020
Credits: 1.00 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Taking a New Look at Cancer-Associated Venous Thromboembolism: How Is Emerging Evidence Influencing Guidelines & Practice?
Robert D. McBane, MD
June 30, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Immunotherapy as a Component of Multimodal Therapy in Locally Advanced and Earlier Stages of Lung Cancer: Rationale, Evidence, and Implications for the Multidisciplinary Team
Brendon Stiles, MD
June 25, 2020
Credits: 0.50 CME / MOC
Penn State College of Medicine
Chair’s Take on Innovation in Prostate Cancer: Thoughts on New Evidence
William K. Oh, MD
June 22, 2020
Credits: 0.50 CME / MOC
Penn State College of Medicine
Innovative Treatments for Bladder Cancer: Thoughts From the Chair
Arjun Balar, MD
June 22, 2020
Credits: 1.00 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Finding the Path to Clinically Meaningful Outcomes Among Expanding Treatment Options in Renal Cell Carcinoma
Hans J. Hammers, MD, PhD
June 18, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Chair's Take: Latest and Emerging Evidence of PARP Inhibitors in Ovarian Cancer Management
Bradley J. Monk, MD, FACS, FACOG
June 18, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Chair's Take: HER2-Targeted and Other Agents for Gastric Cancer
David H. Ilson, MD, PhD
June 17, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Transforming Care With BTK Inhibitors in CLL: New Insights on Therapy Selection, Safety, and Agent Sequencing Across the Treatment Continuum
Florence Cymbalista, MD, PhD
June 17, 2020
Credits: 0.50 CME / MOC
Penn State College of Medicine
Fueling Innovation in Multiple Myeloma: Thoughts From the Chair
Sagar Lonial, MD, FACP
June 16, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Chair’s Take on Advances in Gynecologic Cancer Care: Exploring New Advances and Innovative Therapies in Endometrial and Cervical Cancers
Linda R. Duska, MD, MPH
June 16, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Advances in AML Care: Highlights From Recent Science
Harry P. Erba, MD, PhD
June 15, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Chair's Take: Everything You Need to Know About Biomarkers, Immunotherapies, Combinations, and Other Emerging Approaches for Lung Cancer
Suresh S. Ramalingam, MD, FACP, FASCO
June 15, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Chair’s Take: Review of the Latest HCC Therapy Advancements
Richard S. Finn, MD
June 12, 2020
Credits: 0.50 CME / MOC / CPE
Medical Learning Institute, Inc.
Teaming Up to Reduce the Burden of Cancer-Associated VTE: Applying the Latest Guidelines and Evidence in Gastrointestinal and Hematologic Malignancies and Other Cancer Settings
Alok A. Khorana, MD, FACP, FASCO
June 11, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Chair's Take on Immunotherapy as a Component of Multimodal Therapy in Locally Advanced and Earlier Stages of Lung Cancer: Rationale, Evidence, and Implications for the Multidisciplinary Team
Brendon Stiles, MD
June 10, 2020
Credits: 1.00 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Deep Insight Into Immuno-Oncology: A Visual Exploration of Current and Emerging Pathways, Targets, and Biomarkers to Maximize the Potential of Cancer Immunotherapies
Nadeem Riaz, MD, MSc
May 29, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Targeting Pathogenic Mutations in the DNA Damage Response Pathway: Genetic Testing and Counseling in the Era of Precision Medicine and Next-Generation Sequencing
Mike Janicek, MD / Bradley J. Monk, MD, FACS, FACOG
May 27, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Expert Views on the Evolving Role of PARP Inhibitors in the Treatment of Ovarian Cancer
Bradley J. Monk, MD, FACS, FACOG
April 30, 2020
Credits: 1.00 CME / MOC / CC / CNE
Medical Learning Institute, Inc.
Improving Outcomes in Patients With Molecularly Altered NSCLC Through Broad Implementation of Precision Testing and Treatment: Latest Evidence and Practical Guidance in the Context of a Changing Targeted Therapy Landscape
Alexander Drilon, MD
April 30, 2020
Credits: 1.00 CME / MOC / CNE / CPE
Purdue University
Biosimilars as Partners in Oncology: Expert Guidance on Understanding and Incorporating Biosimilar Agents in Real-World Care
Hope S. Rugo, MD, FASCO
April 28, 2020
Credits: 1.50 CME / CC
Medical Learning Institute, Inc.
Increasing Importance of HER2 and HER3 Testing in the Context of an Expanding Targeted Therapies Landscape for Breast, Gastrointestinal, Lung, and Other Cancers: Latest Updates and Practical Guidance for Pathologists
Farnaz Dadmanesh, MD
April 6, 2020
Credits: 1.00 CME
The Medical College of Wisconsin
Changing Perspectives on Multiple Myeloma and ASCT: Clinical Decision-Making, New Evidence, and Expanding Therapeutic Options
Sagar Lonial, MD, FACP
March 31, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Multimodal Head and Neck Cancer Care Meets the Immunotherapy Era: A Look at the Changing Nature of Multidisciplinary Collaboration and Integrated Treatment Strategies
Barbara Burtness, MD
March 31, 2020
Credits: 1.00 CME
The Medical College of Wisconsin
State-of-the-Art Solutions for Myelofibrosis: The Intersection of JAK Inhibitors, Allogeneic Transplant, and Other Strategies for Patient Care
Prithviraj Bose, MD
March 23, 2020
Credits: 1.50 CME
Purdue University College of Pharmacy
Mapping the Pathways to Better Patient Outcomes in Prostate Cancer: Personal Insights and Guidance From the Patient CaseBook
William K. Oh, MD
March 18, 2020
Credits: 1.50 CME / MOC
Penn State College of Medicine
Raising the Bar With Innovative Therapy for Bladder Cancer: Insights on Clinical Decision-Making in the New Era of Care
Arjun Balar, MD
March 17, 2020
Credits: 1.00 CME
The Medical College of Wisconsin
The Continuing Wave of Innovation in AML: Getting the Most From the Convergence of Novel Therapy and Allogeneic Transplant
Harry P. Erba, MD, PhD / James M. Foran, MD, FRCPC
March 13, 2020
Credits: 1.00 CME
The Medical College of Wisconsin
Taking the Leap With CAR T: Opportunities for Improving Care and Optimizing Cell Therapy in Hematologic Cancers
Michael R. Bishop, MD
March 12, 2020

Pages